| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/31/2009 | CA2339792C Opthalmic solution with tetracycline for topical treatment of dry eye disease |
| 03/31/2009 | CA2337175C Treatment of restenosis |
| 03/31/2009 | CA2317582C A drug dosage form based on the teorell-meyer gradient |
| 03/31/2009 | CA2307285C Agent for prophylaxis and treatment of glaucoma |
| 03/31/2009 | CA2193627C Subcutaneous implant |
| 03/31/2009 | CA2193597C Otic microbial combinations |
| 03/26/2009 | WO2009039262A2 Steroid containing ophthalmic drug delivery systems |
| 03/26/2009 | WO2009039226A1 Lyophilized pharmaceutical compositions |
| 03/26/2009 | WO2009039157A2 Orlistat pharmaceutical formulations |
| 03/26/2009 | WO2009039049A1 Dip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum |
| 03/26/2009 | WO2009038922A1 Forming embolic particles |
| 03/26/2009 | WO2009038868A1 Cytocompatible alginate gels |
| 03/26/2009 | WO2009038783A1 Biocompatible foams, systems, and methods |
| 03/26/2009 | WO2009038778A1 Topical product containing sacrificial material for neutralizing free radicals |
| 03/26/2009 | WO2009038701A2 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 03/26/2009 | WO2009038591A1 Bile salt colloids and methods of making and using thereof |
| 03/26/2009 | WO2009038340A1 Pharmaceutical composition of artemisia extract using gastro-retentive drug delivery system and its oral sustained release formulation |
| 03/26/2009 | WO2009038217A1 Calcium secondary phosphate anhydride particle and method for producing the same |
| 03/26/2009 | WO2009038145A1 Method of producing granules containing material of natural origin such as chinese orthodox medicine extract, crude drug extract, natural material extract or mixture thereof and method of producing tablets from the granules |
| 03/26/2009 | WO2009038106A1 Oral administration drug containing alanyltyrosine |
| 03/26/2009 | WO2009038008A1 Process for producing fine particles and the fine particles |
| 03/26/2009 | WO2009037813A1 Transdermally absorbable preparation |
| 03/26/2009 | WO2009037704A1 Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone |
| 03/26/2009 | WO2009037584A2 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 03/26/2009 | WO2009037482A2 Microcapsules and methods |
| 03/26/2009 | WO2009037449A1 Solid pharmaceutical compositions comprising one or more herpes virus inhibitors and one or more reverse transcriptase inhibitors |
| 03/26/2009 | WO2009037401A1 System for controlled release of an active principle and method for preparation |
| 03/26/2009 | WO2009037319A2 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine |
| 03/26/2009 | WO2009037313A1 Amphiphilic copolymers and compositions containing such polymers |
| 03/26/2009 | WO2009037310A2 Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules |
| 03/26/2009 | WO2009037264A2 Colonic delivery of antimicrobial agents |
| 03/26/2009 | WO2009037183A2 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia |
| 03/26/2009 | WO2009037114A1 Medium for the treatment of mouth and throat in the form of tablets |
| 03/26/2009 | WO2009036999A1 Drug delivery system |
| 03/26/2009 | WO2009036851A2 Use of microcapsules and microcapsule |
| 03/26/2009 | WO2009036812A1 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 03/26/2009 | WO2009036811A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 03/26/2009 | WO2009036712A2 Dosage form containing tramadol with controlled 24-hour release and a process for manufacturing the same |
| 03/26/2009 | WO2009036565A1 Enteric coatings for orally ingestible compositions |
| 03/26/2009 | WO2009018373A3 Transdermal administration of (2s) - (4e) -n-methyl-5- (3- ( 5-is0pr0p0xypyridin) yl) -4-penten-2-amine |
| 03/26/2009 | WO2009017812A3 Pharmaceutical composition of candesartan |
| 03/26/2009 | WO2009016577A3 A pharmaceutical composition comprising atorvastatin and niacin |
| 03/26/2009 | WO2009016547A3 Device for ophtalmic treatments and methods for making said device |
| 03/26/2009 | WO2009015014A3 Multi-step method of pain and/or inflammation treatment |
| 03/26/2009 | WO2009005769A3 Soft gel systems in modulating stem cell development |
| 03/26/2009 | WO2009001019A3 Nanocapsules with liquid lipidic core loaded with water-soluble or water-dispersible ingredient(s) |
| 03/26/2009 | WO2008157614A9 Sustained intraocular delivery of drugs from biodegradable polymeric microparticles |
| 03/26/2009 | WO2008151811A3 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 03/26/2009 | WO2008151235A3 Compositions for delivering medicaments into the lungs, uses thereof |
| 03/26/2009 | WO2008145943A3 Vehicle in the form of a water-in-oil emulsion in particular for ophthalmic or dermocosmetic use |
| 03/26/2009 | WO2008127743A3 Composition for targeted drug delivery and controlled release |
| 03/26/2009 | WO2008117268A3 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
| 03/26/2009 | WO2008112661A3 Heating unit for use in a drug delivery device |
| 03/26/2009 | WO2008104852A3 Pharmaceutical compositions comprising adsorbate of fenofibrate |
| 03/26/2009 | WO2008076819A3 Human growth hormone formulations |
| 03/26/2009 | WO2008074488A3 Construction and use of transfection enhancer elements |
| 03/26/2009 | WO2008073193A3 Ocular devices and methods of making and using thereof |
| 03/26/2009 | WO2008056021A3 Granules, tablets and granulation |
| 03/26/2009 | WO2008029386A3 Systems, methods and compositions for treatment and use of a palatal patch |
| 03/26/2009 | WO2008017914A3 Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (miscrosponged benzoyl peroxide) |
| 03/26/2009 | WO2007112287A3 Hme transdermal compositions containing testosterone |
| 03/26/2009 | WO2007092620A3 Stable formulations, and methods of their preparation and use |
| 03/26/2009 | WO2005018486A3 Use of melatonin-containing oral supplement with animals |
| 03/26/2009 | US20090082860 Ocular Implants with Asymmetric Flexibility |
| 03/26/2009 | US20090082855 Coating for controlled release of a therapeutic agent |
| 03/26/2009 | US20090082717 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 03/26/2009 | US20090082384 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090082255 by addition of surfactants providing a high long-term stability due to stress; storage stability to hydrophobic aggregation nuclei for several months under temperature stress; for the treatment of diabetes; FDA Orange book listed patent for insulin glargine recombinant |
| 03/26/2009 | US20090082250 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
| 03/26/2009 | US20090081415 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process |
| 03/26/2009 | US20090081309 Stabilized Oral Suspension Formulation |
| 03/26/2009 | US20090081308 Anhdyrous lactose agglomerates and the preparation thereof |
| 03/26/2009 | US20090081306 Microencapsulated materials and method of making same |
| 03/26/2009 | US20090081305 Compositions and Methods for Enhancing In-Vivo Uptake of Pharmaceutical Agents |
| 03/26/2009 | US20090081304 Composite pigment nanoparticles and processes to form organic-inorganic nanoparticle composite particles |
| 03/26/2009 | US20090081303 Pharmaceutical formulation for contraception and hormone-replacement therapy |
| 03/26/2009 | US20090081302 Pulmonary delivery of polyene antifungal agents |
| 03/26/2009 | US20090081301 Microparticle dispersion liquid manufacturing method and microparticle dispersion liquid manufacturing apparatus |
| 03/26/2009 | US20090081300 Agent for use in the case of fructose intolerance |
| 03/26/2009 | US20090081299 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081298 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081297 Use of surface tension reducing agents in aerosol formulations |
| 03/26/2009 | US20090081296 Extracorporeal cell-based therapeutic device and delivery system |
| 03/26/2009 | US20090081295 Nanoclusters for delivery of therapeutics |
| 03/26/2009 | US20090081294 Sustained release dosage form for lubricating an oral cavity |
| 03/26/2009 | US20090081293 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081292 Oil-containing solid product and process for producing the same |
| 03/26/2009 | US20090081291 Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User |
| 03/26/2009 | US20090081290 Tamper resistant dosage forms |
| 03/26/2009 | US20090081289 Plant and a process for production of tablets |
| 03/26/2009 | US20090081288 Orodispersible Domperidone Tablets |
| 03/26/2009 | US20090081287 Pharmaceutical Composition Containing Gelling Agent |
| 03/26/2009 | US20090081286 Extended release venlafaxine formulation |
| 03/26/2009 | US20090081285 Use of radical-capturing substances in a topical preparation for antipyretic treatment |
| 03/26/2009 | US20090081284 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface |
| 03/26/2009 | US20090081283 Tumor therapy with non-viral-based high affinitiy laminin receptor-targeted vectors |
| 03/26/2009 | US20090081282 Pharmaceutical composition for treating cancer |
| 03/26/2009 | US20090081281 Photosensitizer Formulation for Topical Applications |